Menopause Market

Menopause Market By Treatment Type (Hormonal Products, Non-Hormonal Products, and Dietary Supplements), Distribution Channel (Hospitals, Retail, and Online Pharmacies), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing female aging population as well as more emphasis on creating awareness regarding menopause treatment

The global menopause market was valued at USD 15.53 billion in 2023, growing at a CAGR of 7.10% during the forecast period from 2024 to 2030 to reach USD 23.44 billion by 2030. The demand for products that help in the management of menopause symptoms is witnessing a surge majorly due to the rising female aging population wherein age plays a prominent role in regulating the menstrual cycle and the growing awareness regarding menopause among people, thereby boosting the growth of the menopause market during the forecast period from 2024-2030.

Menopause Market Dynamics:

One of the key factors driving the demand for menopause is the rising aging population of females globally.

As per the figures quoted by the World Health Organization (WHO) (2020) in their Decade of Healthy Ageing (2020–2030) Report, people in the age group of 60 years and above will account for a 34% higher share in the total population growing from one billion in 2019 to 1.4 billion in 2030. Since women live longer than men, on average, they comprise the majority of older persons, especially at advanced ages.

According to statistics by the World Bank Data (2022), there were 422,581,897 females aged 65 and above globally in 2021.

Aging and menopause are well-established phenomena wherein the decreased production of estrogen and reduction in the number of ova as well as ovarian aging are all collectively related to the onset of menopause. Thus as one age, the reproductive cycle begins to slow down and prepares to stop.

The process by which the body adjusts to various hormone levels can also result in physical changes. The body adjusts to these changes through some menopause symptoms during each stage such as perimenopause, menopause, and postmenopause.

Thus, the rising geriatric population of females globally will lead to more women experiencing and going through menopause phases, thus increasing the market demand for the overall menopause market during the forecast period.

However, side effects associated with hormonal therapy and difficulty in diagnosing menopause may be certain growth-restricting factors for the menopause market.

Menopause Market Segment Analysis:

Menopause Market by Treatment Type (Hormonal Products, Non-Hormonal Products, and Dietary Supplements), Distribution Channel (Hospitals, Retail, and Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the treatment type segment of the menopause market, the dietary supplements category is expected to register a healthy CAGR in terms of market growth during the forecast period.

The wide applications and the various advantages associated with the use of dietary supplements along with the product development activities such as recent launches are expected to bolster the market demand for dietary supplements in the forthcoming years.

The benefits of supplements for menopause symptoms are well established. Supplements such as vitamin supplements can help ease the nagging, and sometimes exhausting side effects of menopause including vaginal dryness, hot flashes, and weight gain.

As a possible alternative to hormone replacement therapy, a healthful diet, regular exercise, and using menopause-focused multivitamins can all help reduce menopause symptoms significantly.

In October 2022, PharmaLinea launched Your Meno Ease advanced ‘whole body’ menopause supplement offering pain relief as well as benefitting cardio-metabolic, brain, and bone health.

The supplement contains soy isoflavones, resveratrol, and vitamin B6, which is clinically shown to affect phytoestrogen activity, improve cerebral blood flow and vasodilation, improve cognitive performance and insulin sensitivity, slow down bone mineral density loss, and reduce chronic pain.

Thus, the interplay of all the above-mentioned factors is likely to expand the market for dietary supplements during the forecast period from 2024-2030.

Asia-Pacific is expected to register the fastest growth in the overall Menopause Market:

Among all the regions, Asia Pacific is estimated to register the fastest growth in terms of CAGR in the menopause market. This trend in the regional growth of the market can be ascribed to the fact that the APAC region is expected to be home to the fastest-growing aging population majorly women. Furthermore, the scope for creating more awareness among the population regarding menopause would act as a key factor for product manufacturers to generate more revenue from the region in the coming years.

According to statistics by the Elderly in India 2021 report, India has nearly 138 million elderly persons, comprising 67 million males and 71 million females.

Also, the proportion of the elderly population in India has increased to 10.1% in 2021 and is further likely to increase to 13.1% in 2031.

As one age, the reproductive cycle begins to slow down and prepares to stop, as this cycle has been continuously functioning since puberty. With age as menopause nears, the ovaries make less of a hormone called estrogen. When this decrease occurs, the menstrual cycle (period) starts to change, gradually becoming irregular and then stops, ultimately leading to menopause. Thus, with increasing age, the market for menopause in India is expected to increase in demand in the upcoming years.

In August 2022, Vedistry, a part of Charak Pharma Group, launched a nutritional supplement, Fortyfitt Woman Tablets in India, to help women fight perimenopause and menopause symptoms. Being packed with the combination of soya phytoestrogens and nutraceuticals like green tea, ginseng, grape seed, and omega-3 fatty acids, they help women with a smooth transition from perimenopause to menopause and overall health in their forties.

Thereby, the interplay of all the above-mentioned factors is expected to drive the market growth for menopause in the region during the forecast period from 2024-2030.

Menopause Market Key Players:

Some of the key menopause companies operating in the menopause market include ISIDEN, Novapharm, Arkopharma, Pileje, Thermamex, ÉLERTÉ Laboratories, Serelys Pharma, Besins Healthcare, Bayer, ITALFARMACO S.p.A, Pfizer Inc, Mylan NV, Teva Pharmaceuticals, TherapeuticsMD, Inc, Novo Nordisk, Novartis, Millicent Pharma, PADAGIS LLC, Vertical Pharmaceuticals LLC, Amgen, and others.

Recent Developmental Activities in Menopause Market:

• In September 2021, Theramex received regulatory approval for Bijuva® / Bijuve® (1mg estradiol / 100mg progesterone) across Europe and the UK. It is the first, and only, body-identical hormone therapy treatment (HRT) for estrogen deficiency symptoms in postmenopausal women with intact uterus and to be administered orally.
• In April 2019, Amgen and UCB (Euronext Brussels: UCB) received regulatory approval from the U.S. Food and Drug Administration (FDA) for EVENITY™ (romosozumab-aqqg) which is intended for the treatment of osteoporosis in postmenopausal women at high risk for fracture. 

Key Takeaways from the Menopause Market Report Study

• Market size analysis for current menopause market size (2023), and market forecast for 6 years (2024-2030)
• Top key menopause product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key menopause companies are dominating the global menopause market.
• Various opportunities are available for the other competitors in the menopause market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current menopause market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for menopause market growth in the coming future?

Target Audience who can be benefited from this Menopause Market Report Study

• Menopause products providers
• Research organizations and consulting companies 
• Menopause-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in menopause products
• Various End-Users who want to know more about the menopause market and the latest developments in the menopause market.